chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Mydriasis, Paraesthesia, Tinnitus, Tremor, Visual impairment
Clinical narrative: tingling feeling down right arm; shooting pain in upper back and shoulder (right side); shooting pain in upper back and shoulder (right side); shake; ringing in her ears; pupils were completely dilated; felt warm to the touch; momentary light-headed feeling; vision began to blackout, then her vision when to all white; vision began to blackout, then her vision when to all white; This is a spontaneous report from a contactable consumer.   A 16-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 17:30 (Batch/Lot Number: ER8733 7/21 6023043) as DOSE 1, SINGLE (at the age of 16 years) for covid-19 immunisation.  Medical history included anxiety from an unknown date. No Known allergies. Patient did not have COVID prior vaccination. There was no COVID tested post vaccination. Concomitant medications included bupropion hydrochloride (BUPROPION HCL XL) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported.  The patient experienced vision began to blackout, then her vision when to all white (medically significant) on 01Apr2021 with outcome of recovered , vision began to blackout, then her vision when to all white on 01Apr2021 with outcome of recovered , immediate tingling feeling down right arm following vaccination on 01Apr2021 17:30 with outcome of recovered , A few minutes (3-5) later shooting pain in upper back and shoulder on 01Apr2021 with outcome of recovered , shake  on 01Apr2021 with outcome of recovered , ringing in her ears on 01Apr2021 with outcome of recovered , pupils were completely dilated on 01Apr2021 with outcome of recovered , felt warm to the touch on 01Apr2021 with outcome of recovered. An ambulance was called. Approximately 10 minutes later she began to feel better and did not go to the hospital. 4 hours later she had a momentary light-headed feeling 01Apr2021 with outcome of recovered.  No other vaccine given in four weeks.  No treatment was given.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: Both feet swollen particularly toe area.; Bad rash on left foot, slightly less on right. On left leg a minor rash.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the right arm on 15Mar2021 at 14:00 (at the age of 70-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN8728) via an unspecified route of administration in the left arm on 08Apr2021 at 14:45 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included sinusitis, knee pain and surgery. The patient previously received some sulfa drugs (MANUFACTURER UNKNOWN) for unknown indication and on unknown dates and experienced sulfonamide allergy. Concomitant medications included apixaban (ELIQUIS), duloxetine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and aripiprazole (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00, the patient experienced both feet swollen particularly toe area, which was badly swollen one night ago, bad rash on left foot, slightly less on right and on left leg a minor rash. It was unknown whether therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events both feet swollen particularly toe area, bad rash on left foot, slightly less on right and on left leg a minor rash was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Dizziness, Migraine, Nausea, Rash
Clinical narrative: 48 hours later, I know have a rash all over my body and breaking into hives.; 48 hours later, I know have a rash all over my body and breaking into hives.; 4 hours after getting the vaccine, I started to feel nauseous; Dizzy; Horrible migraine; Can't move out of bed. I felt like that for two days.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 09Apr2021 at 13:30 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfonamide allergy (sulfa). The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine.  The patient previously took erythromycin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 13:30 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 17:30, 4 hours after getting the vaccine, the patient felt nauseous, dizzy, horrible migraine and "can't move out of bed". The patient felt like that for two days. On 11Apr2021, 48 hours after vaccination, the patient experienced rash all over body and breaking into hives. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events feeling nauseous, dizzy, horrible migraine, can't move out of bed, rash all over body and breaking into hives was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: 48 hours later, I know have a rash all over my body and breaking into hives.; 48 hours later, I know have a rash all over my body and breaking into hives.; 4 hours after getting the vaccine, I started to feel nauseous; Dizzy; Horrible migraine; Can't move out of bed. I felt like that for two days.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 09Apr2021 at 13:30 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfonamide allergy (sulfa). The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine.  The patient previously took erythromycin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 13:30 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 17:30, 4 hours after getting the vaccine, the patient felt nauseous, dizzy, horrible migraine and "can't move out of bed". The patient felt like that for two days. On 11Apr2021, 48 hours after vaccination, the patient experienced rash all over body and breaking into hives. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events feeling nauseous, dizzy, horrible migraine, can't move out of bed, rash all over body and breaking into hives was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nosebleed; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 13Mar2021 at 14:45 (at the age of 21-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 06Apr2021 at 08:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to all seeds, tree nuts, peanuts, crab, soy and cats. Before 13Mar2021, in at least a year or more, the patient had not had any nosebleeds. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 14Mar2021 at 03:00, the patient woke up in the middle of the night with a nosebleed and resolved on the same day. The patient had not had any other nosebleeds between 14Mar2021 to 08Apr2021. Then on 09Apr2021 at 07:00, the patient experienced another nosebleed. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event nosebleed with onset of 09Apr2021 at 07:00 was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Pain in extremity, Paraesthesia, SARS-CoV-2 test
Clinical narrative: My upper arm near the injection sight felt like it was broken and burning; my palm and wrist was numb and tingling and I could not feel my fingers or pic anything up; my palm and wrist was numb and tingling; I was awoken in the middle of the night by the worst pain I ever experienced; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 12:00 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The medical history were reported as none. Concomitant medications included cetirizine hydrochloride and ibuprofen, all from unknown dates and for unknown indications. It was unknown whether the patient had any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient underwent SARS-CoV-2 (nasal swab) test and the result was negative. On 10Apr2021, the patient was awoken in the middle of the night by the worst pain that the patient had ever experienced and at 06:00, the patient's upper arm near the injection sight felt like it was broken and burning, his palm and wrist was numb and tingling and he could not feel his fingers or pic anything up. It was unknown whether any therapeutics measures were taken as a result of the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events patient awoken by worst pain, upper arm near the injection sight felt like broken and burning, palm and wrist was numb and tingling, couldn't feel finger or pic anything up were unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature decreased, Body temperature increased, Chills, Headache, Hyperhidrosis
Clinical narrative: Vomiting; Body temperature low (95.5 degrees F); Low body temperature after vomiting (95.5 degrees F) with excessive sweating; Body aches; Chills; Headache; Nausea; Fever of 100.4; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 10:15(at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, migraine, GERD (gastroesophageal reflux disease), mitral valve prolapse and penicillin allergy. Concomitant medications included escitalopram oxalate (LEXAPRO) and sumatriptan succinate (IMITREX) and multivitamin (MANUFACTURER UNKNOWN) all for unknown indications, from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 11:45 the patient experienced vomiting, low body temperature after (95.5 degrees F), excessive sweating, body aches, chills, headache, nausea and fever of 100.4. The patient did not receive any treatment for the event. The patient underwent lab tests and procedures, which included body temperature on 08Apr2021 and the result was 95.5 degrees F and body temperature with the result was fever of 100.4. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vomiting, low body temperature (95.5 degrees F), excessive sweating, body aches, chills, headache, nausea and fever of 100.4 were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Vomiting; Body temperature low (95.5 degrees F); Low body temperature after vomiting (95.5 degrees F) with excessive sweating; Body aches; Chills; Headache; Nausea; Fever of 100.4; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 10:15(at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, migraine, GERD (gastroesophageal reflux disease), mitral valve prolapse and penicillin allergy. Concomitant medications included escitalopram oxalate (LEXAPRO) and sumatriptan succinate (IMITREX) and multivitamin (MANUFACTURER UNKNOWN) all for unknown indications, from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 11:45 the patient experienced vomiting, low body temperature after (95.5 degrees F), excessive sweating, body aches, chills, headache, nausea and fever of 100.4. The patient did not receive any treatment for the event. The patient underwent lab tests and procedures, which included body temperature on 08Apr2021 and the result was 95.5 degrees F and body temperature with the result was fever of 100.4. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vomiting, low body temperature (95.5 degrees F), excessive sweating, body aches, chills, headache, nausea and fever of 100.4 were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Loud ringing in ears within 30 minutes of 2nd dose; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 19Mar2021 at 11:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 26Feb2021 at 13:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 12:30, the patient experienced loud ringing in ears within 30 minutes of second dose. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event loud ringing in ears within 30 minutes of second dose was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Fatigue, Nasal congestion, Pain
Clinical narrative: Tired, no energy; congestion; sneezing; coughing; low appetite; sleeping during the day; achy; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 14:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medication, food or any other products. Concomitant medications included naproxen sodium (ALEVE), vitamin nos , minerals nos  (CENTRUM) all for unknown indication, unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 14:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 20:00 the patient experienced tired, no energy, achy, congestion, sneezing, coughing, low appetite and sleeping during the day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures was taken as a result of the events. The clinical outcome of the events tired, no energy, achy, congestion, sneezing, coughing, low appetite and sleeping during the day were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Sneezing, Somnolence
Clinical narrative: Tired, no energy; congestion; sneezing; coughing; low appetite; sleeping during the day; achy; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 14:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medication, food or any other products. Concomitant medications included naproxen sodium (ALEVE), vitamin nos , minerals nos  (CENTRUM) all for unknown indication, unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 14:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 20:00 the patient experienced tired, no energy, achy, congestion, sneezing, coughing, low appetite and sleeping during the day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures was taken as a result of the events. The clinical outcome of the events tired, no energy, achy, congestion, sneezing, coughing, low appetite and sleeping during the day were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Akathisia
Clinical narrative: Akathisia; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 10Apr2021 at 09:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had known allergies to penicillin. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 20Mar2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021 at 00:00, the patient experienced akathisia. No therapeutic measures were taken as a result of reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event akathisia was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart palpitations; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 the patient experienced heart palpitations. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the event. The clinical outcome of the event heart palpitations was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Body aches for 12 hours; This is a spontaneous report from a contactable consumer, the parent. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 10Apr2021 at 10:30 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 09:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 22:00 the patient experienced fever, chills, and body aches for 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills, and body aches for 12 hours were recovered on 11Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Urticaria
Clinical narrative: Hives; Headache; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0153) via an unspecified route of administration in the right arm on 07Apr2021 at 17:15 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for unspecified indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP69SS), via an unspecified route of administration in the left arm on 16Mar2021 at 17:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19.  The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:30, the patient experienced hives and headache. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcomes of the events hives and headache was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Gastrointestinal pain, Malaise, Nausea
Clinical narrative: Nausea; Intestinal cramps; Kidney pain; Fatigue; Loose stool; Pain at injection site; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 02Apr2021 at 08:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included depression, adhd, raynaud's syndrome and patulous eustachian tube. The patient did not have any known allergies. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ), lisdexamfetamine mesilate (VYVANSE), iron (MANUFACTURER UNKNOWN) 65 mg, ascorbic acid, pyridoxine hydrochloride, biotin, tocopheryl acetate, folic acid, thiamine hydrochloride, cyanocobalamin, riboflavin, choline bitartrate, inositol, nicotinamide, calcium pantothenate, glutamic acid, bioflavonoids nos, methyl hesperidin (B 100) and tyrosine (L-TYROSIN) 750 mg; all from unknown dates for unspecified indications. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 17:00, the patient experienced nausea, intestinal cramps, kidney pain, fatigue, loose stool, pain at injection site and malaise. Therapeutic measures were taken as a result of nausea, intestinal cramps, kidney pain, fatigue, loose stool, pain at injection site and malaise which included self-treatment with motrin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events nausea, intestinal cramps, kidney pain, fatigue, loose stool, pain at injection site and malaise were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Renal pain, Vaccination site pain
Clinical narrative: Nausea; Intestinal cramps; Kidney pain; Fatigue; Loose stool; Pain at injection site; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 02Apr2021 at 08:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included depression, adhd, raynaud's syndrome and patulous eustachian tube. The patient did not have any known allergies. Concomitant medications included desvenlafaxine succinate monohydrate (PRISTIQ), lisdexamfetamine mesilate (VYVANSE), iron (MANUFACTURER UNKNOWN) 65 mg, ascorbic acid, pyridoxine hydrochloride, biotin, tocopheryl acetate, folic acid, thiamine hydrochloride, cyanocobalamin, riboflavin, choline bitartrate, inositol, nicotinamide, calcium pantothenate, glutamic acid, bioflavonoids nos, methyl hesperidin (B 100) and tyrosine (L-TYROSIN) 750 mg; all from unknown dates for unspecified indications. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 17:00, the patient experienced nausea, intestinal cramps, kidney pain, fatigue, loose stool, pain at injection site and malaise. Therapeutic measures were taken as a result of nausea, intestinal cramps, kidney pain, fatigue, loose stool, pain at injection site and malaise which included self-treatment with motrin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events nausea, intestinal cramps, kidney pain, fatigue, loose stool, pain at injection site and malaise were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Malaise, SARS-CoV-2 test
Clinical narrative: Injection site pain; Headache; Chills; Feeling unwell; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced injection site pain, headache, chills, diarrhea and also the patient felt unwell. On 10Apr2021, post vaccination, the patient underwent nasal swab test and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, headache, chills, feeling unwell and diarrhea were resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; Headache; Chills; Feeling unwell; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced injection site pain, headache, chills, diarrhea and also the patient felt unwell. On 10Apr2021, post vaccination, the patient underwent nasal swab test and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, headache, chills, feeling unwell and diarrhea were resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: After receiving the vaccine I had been experiencing nose bleeds; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 14:30 hours (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included HIV. Concomitant medications included rilpivirine hydrochloride, dolutegravir sodium (JULUCA) from an unknown date for unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took sulfamethoxazole and trimethoprim (BACTRIM) on an unknown date and for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 after receiving the vaccine the patient had been experiencing nose bleeds. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event nose bleeds was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Headache, Myalgia, Nausea
Clinical narrative: headache; muscle aches; fatigue; nausea; face felt hot but no increase in body temperature; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ep7533) via an unspecified route of administration in the left arm on 07Apr2021 at 13:15 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced headache, muscle aches, fatigue, nausea and face felt hot but no increase in body temperature. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events headache, muscle aches, fatigue, nausea and face felt hot was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Malaise
Clinical narrative: Feeling unwell; Chills ensued; Temperature began rising continuing to 104.1; Nausea; Vomiting; Headache; Fatigue; Various aches throughout body; Stress; Vein on forehead popped out from the stress; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on 08Apr2021 at 08:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included bundle branch block left. The patient was allergic to shellfish. Concomitant medications included paracetamol (ACETAMINOPHEN) and loratadine (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on 16Mar2021 at 09:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 20:30, within 12 hours, the patient began to experience feeling unwell, chills ensued, her temperature began rising, which continued to 104.1, had nausea, vomiting, headache, fatigue, various aches that began then stopped throughout her body, the vein on her forehead popped out from the stress. Headache, fatigue and nausea were still continued the second day post vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event feeling unwell, chills, temperature began rising continuing to 104.1, vomiting, various aches throughout body, stress and vein on forehead popped out from the stress were resolving. The clinical outcome of the events nausea, headache and fatigue were not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Stress, Vein disorder
Clinical narrative: Feeling unwell; Chills ensued; Temperature began rising continuing to 104.1; Nausea; Vomiting; Headache; Fatigue; Various aches throughout body; Stress; Vein on forehead popped out from the stress; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on 08Apr2021 at 08:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included bundle branch block left. The patient was allergic to shellfish. Concomitant medications included paracetamol (ACETAMINOPHEN) and loratadine (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on 16Mar2021 at 09:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 20:30, within 12 hours, the patient began to experience feeling unwell, chills ensued, her temperature began rising, which continued to 104.1, had nausea, vomiting, headache, fatigue, various aches that began then stopped throughout her body, the vein on her forehead popped out from the stress. Headache, fatigue and nausea were still continued the second day post vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event feeling unwell, chills, temperature began rising continuing to 104.1, vomiting, various aches throughout body, stress and vein on forehead popped out from the stress were resolving. The clinical outcome of the events nausea, headache and fatigue were not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Feeling unwell; Chills ensued; Temperature began rising continuing to 104.1; Nausea; Vomiting; Headache; Fatigue; Various aches throughout body; Stress; Vein on forehead popped out from the stress; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on 08Apr2021 at 08:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included bundle branch block left. The patient was allergic to shellfish. Concomitant medications included paracetamol (ACETAMINOPHEN) and loratadine (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on 16Mar2021 at 09:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 20:30, within 12 hours, the patient began to experience feeling unwell, chills ensued, her temperature began rising, which continued to 104.1, had nausea, vomiting, headache, fatigue, various aches that began then stopped throughout her body, the vein on her forehead popped out from the stress. Headache, fatigue and nausea were still continued the second day post vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event feeling unwell, chills, temperature began rising continuing to 104.1, vomiting, various aches throughout body, stress and vein on forehead popped out from the stress were resolving. The clinical outcome of the events nausea, headache and fatigue were not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Axillary pain, Pain in extremity
Clinical narrative: Arm pain (no redness or swelling); Sever armpit pain (no swelling); This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old unknown gender patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Apr2021(at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included Type 2 diabetes. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN); both from unknown date for unspecified indication. The  patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Mar2021 as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had  not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 the patient experienced Arm pain (no redness or swelling) and severe armpit pain (no swelling). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event arm pain and severe armpit pain was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.